We are live on ! Find out more
SGMT icon

Sagimet Biosciences
SGMT

82 hedge funds and large institutions have $71.6M invested in Sagimet Biosciences in 2024 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 22 increasing their positions, 21 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

1% more funds holding

Funds holding: 81 → 82 (+1)

5% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 21

5% more repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 21

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

36.89% less ownership

Funds ownership: 105.75% → 68.86% (-37%)

42% less capital invested

Capital invested by funds: $122M → $71.6M (-$50.8M)

98% less call options, than puts

Call options by funds: $3K | Put options by funds: $134K

Holders
82
Holders Change
+1
Holders Change %
+1.23%
% of All Funds
1.18%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
22
Increased
22
Reduced
21
Closed
21
Calls
$3K
Puts
$134K
Net Calls
-$131K
Net Calls Change
-$131K

Top Buyers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
+$5.34M
2
Morgan Stanley
Morgan Stanley
New York
+$1.18M
3
Bank of America
Bank of America
North Carolina
+$1.09M
4
Goldman Sachs
Goldman Sachs
New York
+$1.07M
5
Alyeska Investment Group
Alyeska Investment Group
Illinois
+$826K

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$5.14M
2
JP Morgan Chase
JP Morgan Chase
New York
-$4.95M
3
RI
RTW Investments
New York
-$2.29M
4
WP
Woodline Partners
California
-$1.63M
5
Point72 Asset Management
Point72 Asset Management
Connecticut
-$1.38M
Name Holding Trade Value Shares
Change 		Change in
Stake
Jane Street
26
Jane Street
New York
$519K +$586K +127,694 +533%
Northern Trust
27
Northern Trust
Illinois
$513K -$83.8K -18,267 -11%
Citigroup
28
Citigroup
New York
$464K +$600K +130,735 +2,610%
BFM
29
Boothbay Fund Management
New York
$418K – – –
Susquehanna International Group
30
Susquehanna International Group
Pennsylvania
$346K +$336K +73,141 +262%
YIH
31
Y-Intercept (HK)
Hong Kong
$331K +$444K +96,888 New
UBS Group
32
UBS Group
Switzerland
$330K +$152K +33,236 +53%
Squarepoint
33
Squarepoint
New York
$324K +$435K +94,740 New
Verition Fund Management
34
Verition Fund Management
Connecticut
$267K +$289K +63,042 +418%
Victory Capital Management
35
Victory Capital Management
Texas
$265K +$117K +25,480 +49%
Two Sigma Investments
36
Two Sigma Investments
New York
$253K -$5.67K -1,237 -2%
HF
37
HRT Financial
New York
$241K +$324K +70,548 New
Federated Hermes
38
Federated Hermes
Pennsylvania
$233K +$64.2K +14,000 +26%
Acadian Asset Management
39
Acadian Asset Management
Massachusetts
$232K +$154K +33,522 +96%
YF
40
Yu Fan
$196K – – –
EGM
41
Engineers Gate Manager
New York
$190K +$139K +30,343 +120%
State Street
42
State Street
Massachusetts
$185K -$1.05M -229,152 -81%
VF
43
Virtu Financial
New York
$177K +$238K +51,843 New
EAM
44
Exome Asset Management
New York
$173K -$46.8K -10,200 -17%
Barclays
45
Barclays
United Kingdom
$171K +$155K +33,710 +206%
BCM
46
Bridgeway Capital Management
Texas
$154K – – –
CC
47
Centiva Capital
New York
$152K +$204K +44,400 New
JP Morgan Chase
48
JP Morgan Chase
New York
$148K -$4.95M -1,079,980 -96%
XT
49
XTX Topco
Cayman Islands
$142K -$80.8K -17,615 -30%
CAS
50
CTC Alternative Strategies
Illinois
$122K +$164K +35,800 New
1
2
3 4 5

SGMT Hedge Fund Activity: Q2 2024 in Review

82 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Sagimet Biosciences (SGMT) for Q2 2024, worth a combined $71.6M — down 42% from $122M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new SGMT positions and 21 closed out — a net gain of 1 holder — while 22 added to existing stakes and 21 trimmed.

The largest buyer was Citadel Advisors, adding an estimated $5.34M. The largest seller was BlackRock, cutting an estimated $5.14M.

  • 82 institutional investors held Sagimet Biosciences (SGMT) as of Q2 2024, up from 81 in Q1 2024.
  • Funds reported $71.6M of Sagimet Biosciences stock for Q2 2024, down 42% quarter-over-quarter.
  • 22 funds opened new Sagimet Biosciences positions in Q2 2024 and 21 closed out, a net change of +1 holder.
  • The largest Sagimet Biosciences buyer in Q2 2024 was Citadel Advisors, an estimated $5.34M added.
  • The largest Sagimet Biosciences seller in Q2 2024 was BlackRock, an estimated $5.14M sold.

Based on aggregated 13F filings for Q2 2024.